Cargando…
Progress in Multidisciplinary Treatment of Fournier’s Gangrene
Fournier’s gangrene (FG) is a life-threatening and special form of necrotizing fasciitis, characterized by occult onset, rapid progress and high mortality, occurring mainly in men over 50 years of age. Risk factors of FG include diabetes, HIV infection, chronic alcoholism and other immunosuppressive...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717591/ https://www.ncbi.nlm.nih.gov/pubmed/36465810 http://dx.doi.org/10.2147/IDR.S390008 |
_version_ | 1784842932867563520 |
---|---|
author | Zhang, Ke-Fan Shi, Chuan-Xin Chen, Si-Yu Wei, Wei |
author_facet | Zhang, Ke-Fan Shi, Chuan-Xin Chen, Si-Yu Wei, Wei |
author_sort | Zhang, Ke-Fan |
collection | PubMed |
description | Fournier’s gangrene (FG) is a life-threatening and special form of necrotizing fasciitis, characterized by occult onset, rapid progress and high mortality, occurring mainly in men over 50 years of age. Risk factors of FG include diabetes, HIV infection, chronic alcoholism and other immunosuppressive state. FG was previously considered as an idiopathic disease, but in fact, three quarters of the infections originated from the skin, urethra and gastrointestinal tract. Initial symptoms of FG are often inconsistent with severity and can progress promptly to fatal infection. Although the treatment measures of FG have been improved in recent years, the mortality does not seem to have decreased significantly and remains at 20% – 30%. The time to identify FG and the waiting period before surgical debridement are directly related to the prognosis. Therefore, in addition to the combination of intensive fluid resuscitation and broad-spectrum antibiotics, treatment of FG should particularly emphasize the importance of early surgical debridement assisted with fecal diversion and skin reconstruction when necessary. This paper is to briefly summarize the progress in the definition, epidemiology, clinical manifestations, diagnosis, treatment and prognosis of Fournier’s gangrene in recent years, more importantly, illustrates the importance of multidisciplinary cooperation in the management of FG. |
format | Online Article Text |
id | pubmed-9717591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-97175912022-12-03 Progress in Multidisciplinary Treatment of Fournier’s Gangrene Zhang, Ke-Fan Shi, Chuan-Xin Chen, Si-Yu Wei, Wei Infect Drug Resist Review Fournier’s gangrene (FG) is a life-threatening and special form of necrotizing fasciitis, characterized by occult onset, rapid progress and high mortality, occurring mainly in men over 50 years of age. Risk factors of FG include diabetes, HIV infection, chronic alcoholism and other immunosuppressive state. FG was previously considered as an idiopathic disease, but in fact, three quarters of the infections originated from the skin, urethra and gastrointestinal tract. Initial symptoms of FG are often inconsistent with severity and can progress promptly to fatal infection. Although the treatment measures of FG have been improved in recent years, the mortality does not seem to have decreased significantly and remains at 20% – 30%. The time to identify FG and the waiting period before surgical debridement are directly related to the prognosis. Therefore, in addition to the combination of intensive fluid resuscitation and broad-spectrum antibiotics, treatment of FG should particularly emphasize the importance of early surgical debridement assisted with fecal diversion and skin reconstruction when necessary. This paper is to briefly summarize the progress in the definition, epidemiology, clinical manifestations, diagnosis, treatment and prognosis of Fournier’s gangrene in recent years, more importantly, illustrates the importance of multidisciplinary cooperation in the management of FG. Dove 2022-11-28 /pmc/articles/PMC9717591/ /pubmed/36465810 http://dx.doi.org/10.2147/IDR.S390008 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Zhang, Ke-Fan Shi, Chuan-Xin Chen, Si-Yu Wei, Wei Progress in Multidisciplinary Treatment of Fournier’s Gangrene |
title | Progress in Multidisciplinary Treatment of Fournier’s Gangrene |
title_full | Progress in Multidisciplinary Treatment of Fournier’s Gangrene |
title_fullStr | Progress in Multidisciplinary Treatment of Fournier’s Gangrene |
title_full_unstemmed | Progress in Multidisciplinary Treatment of Fournier’s Gangrene |
title_short | Progress in Multidisciplinary Treatment of Fournier’s Gangrene |
title_sort | progress in multidisciplinary treatment of fournier’s gangrene |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717591/ https://www.ncbi.nlm.nih.gov/pubmed/36465810 http://dx.doi.org/10.2147/IDR.S390008 |
work_keys_str_mv | AT zhangkefan progressinmultidisciplinarytreatmentoffourniersgangrene AT shichuanxin progressinmultidisciplinarytreatmentoffourniersgangrene AT chensiyu progressinmultidisciplinarytreatmentoffourniersgangrene AT weiwei progressinmultidisciplinarytreatmentoffourniersgangrene |